[1] |
WU Zhibai, XU Guiqin, ZHANG Li, YANG Zhaojuan, LIU Yun, JIAO Kun, CHEN Zehong, XU Chen, ZUO You, ZHENG Ningqian, YE Zhiqian, LIU Yongzhong.
Mechanism study of KCMF1 promoting proliferation and NF-κB signaling transduction in colorectal cancer cells
[J]. China Oncology, 2024, 34(11): 987-997.
|
[2] |
TAN Xiaolang, YAO Sha, WANG Guihua, PENG Luogen.
Research on uPAR promoting proliferation, migration, and chemoresistance of pancreatic cancer by inhibiting autophagy via MAPK signaling
[J]. China Oncology, 2024, 34(10): 944-956.
|
[3] |
CHEN Hong, CHEN Junxia.
Effect of hsa_circ_0001573 on biological behaviors of breast cancer cells and its molecular mechanism
[J]. China Oncology, 2023, 33(4): 342-353.
|
[4] |
LENG Jie, QIU Guochun, ZHANG Bo, PU Yan.
Mechanism of breast cancer centrosome regulatory protein SEC23B on tumor invasion and metastasis
[J]. China Oncology, 2023, 33(2): 152-161.
|
[5] |
Diao Xinfeng, Li Xinmao, Hou Liang, Wei Zhixuan.
YTHDF2 promotes progression of glioblastoma via inducing mRNA decay of IGFBP7 and activating PI3K/AKT signaling pathway
[J]. China Oncology, 2022, 32(3): 218-227.
|
[6] |
CUI Zhongze, HE Shuang, WEN Feifei, LI Yangyang, XU Xiaoyang, LU Lizhen, WU Shuhua.
Experimental study on influence of autophagy on DPD expression and its effect on chemotherapy with 5-FU in colorectal cancer
[J]. China Oncology, 2022, 32(12): 1199-1209.
|
[7] |
CAO Dalong, YE Dingwei.
New trends and future prospects of regulatory cell death in renal carcinoma
[J]. China Oncology, 2022, 32(10): 1000-1006.
|
[8] |
ZHANG Jiaxiang, ZHOU Yongxue, YAN Shuguang, ZHAO Weihan, DONG Fen.
Research progress of hypoxia-induced mitochondrial autophagy and glucose metabolism reprogramming in gastric precancerous lesions
[J]. China Oncology, 2022, 32(10): 1007-1015.
|
[9] |
CHEN Yifan, SHEN Yihui, CHENG Leilei, LIN Jinyi, ZHANG Hui, WANG Xuejun, XU Yuchen, ZHANG Jian, GE Junbo.
Different preventive effects of four cardioprotective agents on mice with adriamycin-induced cardiotoxicity
[J]. China Oncology, 2022, 32(10): 936-947.
|
[10] |
JIA Zhenzhen, HE Shuang, LI Yangyang, WEN Feifei, XU Xiaoyang, GUO Ningjie, WU Shuhua.
Correlations between expressions of DPD, LC3 and P62 in colorectal cancer and their clinical significance
[J]. China Oncology, 2022, 32(1): 24-33.
|
[11] |
LI Haizhou , ZHANG Yanwei , XU Yingjie , YANG Men , ZHANG Lei , HAN Jingjun .
miR-933 inhibits proliferation, migration and invasion of lung cancer cell lines by regulation of KLF6 gene
[J]. China Oncology, 2021, 31(7): 581-588.
|
[12] |
CAO Dalong, ZHU Wenkai, SHI Guohai, ZHANG Hailiang, WANG Ziliang, YE Dingwei.
The influence of PRUNE2 gene point mutation on proliferation, apoptosis, invasion and migration of prostate cancer DU145 cells
[J]. China Oncology, 2021, 31(6): 441-446.
|
[13] |
HUA Qing, SHEN Xuefang, XU Pingbo .
Effect of KLK8 on apoptosis of colorectal cancer cells by regulating EGF and its mechanism
[J]. China Oncology, 2021, 31(5): 383-389.
|
[14] |
CHEN Guo , HAN Pengli , CHEN Keru , LI Mingchuang , ZHANG Qingsong , CHEN Zheng , DONG Hanhua , QIAN Yuejun , LÜ Jing .
Molecular mechanism of miR-19b-3p regulating apoptosis of medullary thyroid cancer cells by targeting MTUS1
[J]. China Oncology, 2021, 31(5): 390-396.
|
[15] |
CHEN Shaogeng, HE Rongqi, ZHANG Wanfei, LIN Xianzuan, CHEN Heshan, XU Rongyu.
miR-122-5p inhibits the growth of esophageal cancer cells and transplanted tumors by targeting CREB1
[J]. China Oncology, 2021, 31(1): 35-44.
|